Duke University Medical Center
Durham, North Carolina, 27710, United States
NCT Number: NCT05764564
The primary objective of the study is to test the impact of positive and negative body pressure on exercise capacity, symptoms, blood volume distribution and central cardiac hemodynamics in patients with heart failure and preserved ejection fraction. Aim 1 will study healthy volunteers and heart failure patients non invasively while Aim 2 will study heart failure patients invasively (intracardiac pressures).
Looking for future studies?
Notify Me30 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Positive or negative pressure is applied via a closed chamber.
Time frame: Day 1
A positive value indicates greater O2 consumption.
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
A positive value indicates and increase in heart rate.
Time frame: Day 1
A positive value indicates an increase in heart rate.
Time frame: Day 1
A positive value indicates an increase in respiration.
Time frame: Day 1
A positive value indicates an increase in oxygen consumption.
Time frame: Day 1
A positive value indicates an increase in oxygen consumption.
Time frame: Day 1
Time frame: Day 1
Duke University
Other
External Body Pressure and the Impact on Exercise in Heart Failure With Preserved Ejection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05577819
Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related
Boston, Massachusetts, United States
View Trial DetailsNCT05677100
ADHF, Cardio-Renal Syndrome
Phoenix, Arizona, United States
View Trial DetailsNCT07554638
Body Weight, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT07547540
Cardiovascular Diseases, Heart Diseases
Detroit, Michigan, United States
View Trial Details